Could dimephosphon help stroke patients recover faster?

NCT ID NCT07167550

Recruiting now Disease control Sponsor: Tatchempharmpreparaty, JSC Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This Phase 3 trial tests whether the drug Dimephosphon can improve recovery in people who have had an acute ischemic stroke. About 184 adults aged 35-80 will receive either Dimephosphon or a placebo within 24-72 hours of their stroke. The main goal is to see if more patients achieve functional independence (scored 0-2 on the Modified Rankin Scale) by day 15.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dimephosphon
What this could lead to: If successful, Dimephosphon could become a new treatment option to improve recovery after an acute ischemic stroke.
What could go wrong: This is an early Phase 3 trial with only 184 participants. The drug may not prove more effective than placebo, and side effects are still being evaluated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebrovascular disorder ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE STROKE CEREBROVASCULAR DISORDERS ISCHEMIC STROKE PHYSIOLOGICAL EFFECTS OF DRUGS STROKE

Contacts and locations

Locations

Federal State Autonomous Educational Institution of Higher Education "Peoples' Friendship University of Russia named after Patrice Lumumba"
RECRUITING

Moscow, 117198, Russia
Saint Petersburg State Budgetary Healthcare Institution "City Hospital No. 40 of the Kurortny District"
RECRUITING

Saint Petersburg, 197706, Russia
State Budgetary Healthcare Institution "City Hospital No. 4 of Sochi" of the Ministry of Healthcare of the Krasnodar Region
RECRUITING

Sochi, 354057, Russia
State Budgetary Healthcare Institution "Research Institute - Regional Clinical Hospital No. 1 named after Professor S.V. Ochapovsky" of the Ministry of Health of the Krasnodar region
NOT_YET_RECRUITING

Krasnodar, 350086, Russia
State Budgetary Healthcare Institution of the Leningrad Region "Vsevolozhsk Interdistrict Clinical Hospital
RECRUITING

Vsevolozhsk, Leningradskaya Oblast', 188643, Russia
The FSBI "Federal Center of Brain Research and Neurotechnologies" of the Federal Medical and Biological Agency
RECRUITING

Moscow, 117513, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.